178 related articles for article (PubMed ID: 19484260)
1. LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.
Long E; Ilie M; Hofman V; Havet K; Selva E; Butori C; Lacour JP; Nelson AM; Cathomas G; Hofman P
Virchows Arch; 2009 Aug; 455(2):159-70. PubMed ID: 19484260
[TBL] [Abstract][Full Text] [Related]
2. Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions.
Ramos da Silva S; Bacchi MM; Bacchi CE; Elgui de Oliveira D
Am J Clin Pathol; 2007 Nov; 128(5):794-802. PubMed ID: 17951202
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of c-kit expression in classic Kaposi's sarcoma in a cohort of Egyptian patients.
Hussein TM; El-Sabaa BM; Hanafy NF
J Egypt Natl Canc Inst; 2012 Mar; 24(1):1-6. PubMed ID: 23587226
[TBL] [Abstract][Full Text] [Related]
4. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
Cai Q; Murakami M; Si H; Robertson ES
J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma.
Pyakurel P; Massambu C; Castaños-Vélez E; Ericsson S; Kaaya E; Biberfeld P; Heiden T
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):678-83. PubMed ID: 15167286
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi sarcoma skin lesions.
Desnoyer A; Dupin N; Assoumou L; Carlotti A; Gaudin F; Deback C; Peytavin G; Marcelin AG; Boué F; Balabanian K; Pourcher V;
Br J Dermatol; 2016 Dec; 175(6):1251-1262. PubMed ID: 27177037
[TBL] [Abstract][Full Text] [Related]
7. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
8. Latency-associated nuclear antigen expression and human herpesvirus-8 polymerase chain reaction in the evaluation of Kaposi sarcoma and other vascular tumors in HIV-positive patients.
Hammock L; Reisenauer A; Wang W; Cohen C; Birdsong G; Folpe AL
Mod Pathol; 2005 Apr; 18(4):463-8. PubMed ID: 15578080
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Role of IL-32 in HIV-Related Kaposi Sarcoma.
Semango G; Heinhuis B; Plantinga TS; Blokx WAM; Kibiki G; Sonda T; Mavura D; Masenga EJ; Nyindo M; van der Ven AJAM; Joosten LAB
Am J Pathol; 2018 Jan; 188(1):196-203. PubMed ID: 29037857
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions.
Cai Q; Lan K; Verma SC; Si H; Lin D; Robertson ES
J Virol; 2006 Aug; 80(16):7965-75. PubMed ID: 16873253
[TBL] [Abstract][Full Text] [Related]
12. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
13. KSHV downregulation of galectin-3 in Kaposi's sarcoma.
Alcendor DJ; Knobel SM; Desai P; Zhu WQ; Vigil HE; Hayward GS
Glycobiology; 2010 May; 20(5):521-32. PubMed ID: 20040515
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of Bcl-2 in Kaposi's sarcoma lesions varies according to histopathologic stage, whereas expression of Bcl-x and Mcl-1 differs according to human immunodeficiency virus serologic status of patients.
Fernández-Figueras MT; Puig L; Fernández-Vasalo A; Esquius M; Montero MA; Ariza A
Mod Pathol; 2000 Apr; 13(4):438-45. PubMed ID: 10786812
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.
Catrina SB; Botusan IR; Rantanen A; Catrina AI; Pyakurel P; Savu O; Axelson M; Biberfeld P; Poellinger L; Brismar K
Clin Cancer Res; 2006 Aug; 12(15):4506-14. PubMed ID: 16899596
[TBL] [Abstract][Full Text] [Related]
16. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.
Stürzl M; Hohenadl C; Zietz C; Castanos-Velez E; Wunderlich A; Ascherl G; Biberfeld P; Monini P; Browning PJ; Ensoli B
J Natl Cancer Inst; 1999 Oct; 91(20):1725-33. PubMed ID: 10528022
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions.
Pak F; Mwakigonja AR; Kokhaei P; Hosseinzadeh N; Pyakurel P; Kaaya E; Bogdanovic G; Selivanova G; Biberfeld P
Eur J Cancer; 2007 Aug; 43(12):1877-82. PubMed ID: 17627810
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) in cutaneous lesions of Kaposi's sarcoma: a study of formalin-fixed paraffin-embedded tissue.
Herman PS; Shogreen MR; White WL
Am J Dermatopathol; 1998 Feb; 20(1):7-11. PubMed ID: 9504662
[TBL] [Abstract][Full Text] [Related]
19. Unique histologic variants of cutaneous Kaposi sarcoma.
OʼDonnell PJ; Pantanowitz L; Grayson W
Am J Dermatopathol; 2010 May; 32(3):244-250. PubMed ID: 20075709
[TBL] [Abstract][Full Text] [Related]
20. HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry.
Pak F; Pyakural P; Kokhaei P; Kaaya E; Pourfathollah AA; Selivanova G; Biberfeld P
J Cutan Pathol; 2005 Jan; 32(1):21-7. PubMed ID: 15660651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
